Pure Biologics Sets Up Doto Medical SPV To Hurry PB103 Commercialisation

Pure Biologics SA PPUR:

• SETS UP SPV UNDER NAME OF DOTO MEDICAL IN ORDER TO FASTEN COMMERCIALISATION OF PB103 STRATEGIC PROJECT

• ALSO SIGNS DEAL WITH M&A CONSULTANT FIRM CLAIRFIELD PARTNERS TO ACQUIRE STRATEGIC INVESTOR INTERESTED IN COOPERATION UNDER SPV

• COMPANY TO MAINTAIN CONTROL OVER SPV UNTIL ITS SALE TO GLOBAL MED-TECH DEVICES PRODUCER IN 2024